who makes tirzepatide FDA approves new weight loss drug with remarkable track record Tirzepatide | DirectMeds

Dual receptor agonist, the first of its class for weight management

Structure Therapeutics Inc

Lilla, V

Powell W, Song X, Mohamed Y, et al

Seek urgent medical advice (contact your GP or NHS 111) if you experience: Severe or persistent abdominal pain, especially if accompanied by vomiting Persistent vomiting or inability to keep fluids down Signs of dehydration (extreme thirst, dark urine, dizziness) Sudden severe upper abdominal pain radiating to the back (possible pancreatitis) Severe right upper abdominal pain (possible gallstones) Severe bloating with vomiting and no passage of stool or gas (possible obstruction) Persistent or severe gastrointestinal symptoms may indicate the need for dose adjustment or, rarely, discontinuation of therapy

Advertisement Article continues below this ad We must stop looking at employee benefits as a cost to be controlled and start viewing them as an investment in the workforce, Pease said